| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 Jan 2026 | 3 Jan 2026 |
| Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve un-audited financial result for quarter ended December 31, 2025 Outcome of Board Meeting held today i.e., January 30, 2026 for the quarter ended December 31, 2025 (As Per BSE Announcement Dated on:30.01.2026) | ||
| Board Meeting | 31 Oct 2025 | 1 Oct 2025 |
| Quarterly Results-Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 ,inter alia, to consider and approve un-audited financial result for quarter and half year ended September 30, 2025. Outcome of Board Meeting held today i.e., October 31, 2025 for the quarter and half year ended September 30, 2025 (As Per BSE Announcement Dated On : 31.10.2025) Outcome for Board Meeting held today i.e., October 31, 2025 for the quarter and half year ended September 30, 2025 (As Per BSE Announcement Dated on:31.10.2025) | ||
| Board Meeting | 2 Aug 2025 | 9 Jul 2025 |
| Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2025 ,inter alia, to consider and approve un-audited Financial Result for quarter ended June 30, 2025. Outcome of Board Meeting held today i.e., August 02, 2025 for the quarter ended June 30, 2025 (As Per BSE Announcement Dated on: 02/08/2025) | ||
| Board Meeting | 27 May 2025 | 25 Mar 2025 |
| Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2025 Outcome of Board Meeting held today i.e., May 27, 2025 for the quarter and financial year ended March 31, 2025 (As Per BSE Announcement dated on 27.05.2025) | ||
On a sequential basis, revenue increased 7.5% over Q2 FY26, translating into an incremental revenue addition of ₹127 crore during the quarter
Invesco Mutual Fund and Kotak Mahindra Mutual Fund bought 2.6% apiece, while Franklin Templeton Mutual Fund purchased 1.3% stake.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
